California Dental 25-Hour Continuing Education Ebook

_______________________________________________________________ Healthcare-Associated Infections

DEVICE-RELATED INFECTIONS

Type of Device

Prevalence

Probable Cause Typical

Most Common Micro-organisms

Signs and Symptoms

Diagnosis

Treatment

Duration to Occurrence after Implantation

Left ventricular assist devices

25% to 50% Biofilm formation

Within 2 to 6 weeks

Methicillin- resistant staphy- lococcal spp., Pseudomonas spp., Klebsiella spp., E. coli , Enterobacter spp., Proteus spp., Serratia spp., Candida spp., Enterococcus spp. Staphylococcus epidermidis (40% to 45%), S. aureus (25%), Klebsiella spp., Enterobacter spp., Pseudomonas aeru- ginosa , Acineto- bacter baumanii , Corynebacterium spp., Propioni­ bacterium spp., and streptococci/ enterococci

Signs of poor healing, localized inflammation, pocket abscess, frank sepsis, new and persistent drainage

Blood cultures

Empiric therapy with vancomycin and an anti- pseudomonal agent (ceftazidime or ciprofloxacin)

or empiric antifungal therapy

Cerebrospinal fluid (CSF) shunts

10%

Bacteria originating from patient’s skin introduced at time of operation

Within 30 days

Fever, focal pain, ventriculitis with lethargy and malaise (proximal shunts), infected intraperitoneal fluid cysts, or frank peritonitis (distal shunts)

CSF analysis (cell count, glucose, protein), gram stain, culture; abdominal ultra-sonography (distal shunts)

Antimicrobial agent effective against noted micro-organisms, modified with results of culture; removal of shunt

Prosthetic cardiac valves

3% to 5.7% Contamination of the valve at

Within 60 days (early)

Coagulase- negative staphylococci, specifically methicillin- resistant S. epidermidis , S. aureus

Fever, new or changing regurgitant murmurs, CHF, shock, cardiac conduction disturbances on EKG

Blood cultures, transesophageal echocardiog- raphy

Delayed antibi- otic therapy until results of culture available (if subacute course and hemody- namically stable); empiric antibi- otic therapy with vancomycin, gentamicin, rifampin (evidence of significant valve

time of implanta- tion or transient bacteremia

dysfunction); valve replace- ment (new or increasing

murmurs, severe CHF, persistent fever)

S. epidermidis

Penile implants

2% to 8% Contamination at time of implantation

Not available

Erythema, induration, tenderness,

Culture of specimen from the operative site

Empiric antibiotic therapy with

fever, discharge, device extrusion, prosthesis- associated pain

ciprofloxacin or a cephalosporin for 10 to 12 weeks; removal

of implant if pain persists or recurs after antibiotic treatment or if purulent discharge Table 5 continues on next page.

77

EliteLearning.com/Dental

Powered by